Rocket Pharmaceuticals Inc Forecast and Stock Analysis
Technical RCKT stock analysis for Wednesday June 19, 2019.
Rocket Pharmaceuticals Inc gained 1.00% in the last trading day ( Wednesday, 19th Jun 2019 ), rising from $16.92 to $17.09 During day the stock fluctuated 5.00% from a day low at $16.59 to a day high of $17.42. The price has risen in 6 of the last 10 days and is up by 10.33% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 60 545 more shares were traded than the day before. In total, 198 089 shares bought and sold for approximately $3.39 million.
- 30 day high of the RCKT stock price was $17.89 and low was $14.86.
- 90 day high was $20.79 and low was $14.86.
- 52 week high for the Rocket Pharmaceuticals Inc - $25.96 and low - $10.75.
Rocket Pharmaceuticals Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.41% during the next 3 months and, with 90% probability hold a price between $12.99 and $16.35 at the end of this period.
A buy signal was issued from a pivot bottom point on Friday June 14, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Rocket Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $17.14. On a fall, the stock will find some support from the short-term average at $16.68. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSI14 is 54 and the stock is currently not being overbought or oversold
Support & Resistance
Rocket Pharmaceuticals Inc finds support from accumulated volume at $16.99.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.83 between high and low, or 5.00%. For the last week, the stock has had a daily average volatility of 6.04%.
Our recommended stoploss: $16.34 (-4.37%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 3 days ago.)
6.04 %Average volatility
Very Low Low Medium High Very High
Rocket Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|RCKT $17.09 ($0.17 1.00%)|
RCKT is up $0.17 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for RCKT based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the RCKT analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us